Cytomegalovirus (CMV) polyradiculitis is a potentially treatable disorder in patients with the acquired immunodeficiency syndrome (AIDS) 11-41, Response to therapy is variable, but it appears clear that patients treated earlier in their course are more likely to have a favorable response to antiviral therapy 12-41. Although the clinical presentation and cerebrospinal fluid (CSF) formula may suggest the correct diagnosis. most authors have depended on the identification of CMV in culture of CSF, a process that may take several weeks. In a patient with a clinical syndrome suggestive of CMV polyradiculitis, a specific diagnosis was made on a cytopatho-logical examination of a single CSF specimen, allowing for antiviral therapy to be given early in this patient’s course. A 46-year-old human immunodeficiency virus (HIV)- positive
[1]
D. Troost,et al.
Therapy for cytomegalovirus polyradieulomyelitis in patients with AIDS: treatment with ganciclovir
,
1990,
AIDS.
[2]
Robert G. Miller,et al.
Ganciclovir in the treatment of progressive AIDS‐related polyradiculopathy
,
1990,
Neurology.
[3]
R. Miller,et al.
Ganciclovir for lumbosacral polyradiculopathy in AIDS
,
1990,
The Lancet.
[4]
J. McCutchan,et al.
Cytomegalovirus polyradiculoneuropathy in acquired immune deficiency syndrome
,
1987,
Neurology.
[5]
N. Buchan.
Letter: Breast examination in obese patients.
,
1976,
Lancet.